CMS Seeks to Improve Enrollee Experience in 2026 Medicare Advantage and Part D Final Rule But Declines to Include Several Key Proposals

Healthcare attorney Melissa Wong authored an American Health Law Association article analyzing several Inflation Reduction Act (IRA) provisions that the Centers for Medicare & Medicaid Services (CMS) incorporated into its 2026 Medicare Advantage (MA) and Part D Final Rule ahead of the rollout of Maximum Fair Prices under the Medicare Drug Price Negotiation Program. In this piece, Ms. Wong highlights additional changes adopted in the 2026 Final Rule, such as updates to organization determination and coverage decision procedures, and notes which proposed policies CMS chose not to finalize at this time.

READ: CMS Seeks to Improve Enrollee Experience in 2026 Medicare Advantage and Part D Final Rule But Declines to Include Several Key Proposals

Copyright 2025, American Health Law Association, Washington, D.C. Reprint permission granted.